Skip to main content
Grover Bagby Jr., MD, Hematology, Portland, OR

GroverCarltonBagbyJr.MD

Hematology Portland, OR

Physician

Are you Dr. Bagby?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 66 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    3181 SW Sam Jackson Park Rd
    Portland, OR 97239
    Phone+1 503-494-6594
    Fax+1 503-721-7946

Summary

  • Dr. Grover Bagby Jr., MD is a hematologist in Portland, Oregon. He is currently licensed to practice medicine in Oregon. He is affiliated with Portland HCS.

Education & Training

  • Oregon Health & Science University (OHSU Health)
    Oregon Health & Science University (OHSU Health)Fellowship, Hematology and Medical Oncology, 1975 - 1976
  • Oregon Health & Science University (OHSU Health)
    Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 1974 - 1975
  • Oregon Health & Science University (OHSU Health)
    Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 1970 - 1972
  • Baylor College of Medicine
    Baylor College of MedicineResidency, Internal Medicine, 1969 - 1970
  • Baylor College of Medicine
    Baylor College of MedicineInternship, Transitional Year, 1968 - 1969
  • Baylor College of Medicine
    Baylor College of MedicineClass of 1968

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 1971 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1983

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • ‘The Surgeon Is the Method’
    ‘The Surgeon Is the Method’November 23rd, 2021
  • OHSU Marks 20 Years of Life-Saving Cancer Drug
    OHSU Marks 20 Years of Life-Saving Cancer DrugMay 7th, 2021

Grant Support

  • 23rd Annual Fanconi Anemia Research Fund Scientific SymposiumNational Heart, Lung, And Blood Institute2011
  • Fanconi Anemia: Molecular Pathogenesis Of Bone Marrow Failure And Clonal EvolutioNational Heart, Lung, And Blood Institute2010–2011
  • Fanconi Anemia Stem Cells Allow Molecular Characterization Of Acute LeukemiaNational Cancer Institute2008–2011
  • Training Program In Molecular HematologyNational Heart, Lung, And Blood Institute1993–2011
  • Twenty-Second Annual Fanconi Anemia Research Fund Scientific SymposiumNational Institute Of Diabetes And Digestive And Kidney Diseases2010
  • Twenty-First Annual Fanconi Anemia Research Fund Scientific SymposiumNational Institute On Aging2009
  • Prevention And ControlNational Cancer Institute2005–2009
  • Core--Protocol ReviewNational Cancer Institute2005–2009
  • Core--ProteomicsNational Cancer Institute2005–2009
  • Core--Cancer PathologyNational Cancer Institute2005–2009
  • Core--Protocol Specific Research SupportNational Cancer Institute2000–2009
  • Stem Cell Survival Clonal Adaptation And Carcinogenesis In Fanconi AnemiaNational Heart, Lung, And Blood Institute2004–2008
  • Eighteenth Annual Fanconi Anemia Research SymposiumNational Heart, Lung, And Blood Institute2006
  • Ohsu Cancer InstituteNational Cancer Institute2005–2006
  • Fanconi Anemia TranscriptomesNational Center For Research Resources2004–2005
  • Microarray Program For Nhlbi InvestigatorsNational Heart, Lung, And Blood Institute2002–2005
  • Oregon Cancer CenterNational Cancer Institute1997–2004
  • HIV Induced Bone Marrow DysfunctionNational Institute Of Diabetes And Digestive And Kidney Diseases1994–2003
  • Core--Protocol Review And Monitoring SystemNational Cancer Institute2000–2002
  • Dysregulation Of Hematopoiesis In Fanconi AnemiaNational Heart, Lung, And Blood Institute1999–2002
  • Symposium: Progress In Fanconi Anemia ResearchNational Heart, Lung, And Blood Institute2001
  • Core--Clinical Trial Protocol Review And Monitoring SystemNational Cancer Institute1997–1999
  • Hematopoiesis In Fanconi AnemiaNational Heart, Lung, And Blood Institute1994–1998
  • Interleukin-1 And Regulation Of HematopoiesisNational Cancer Institute1994–1995
  • Oregon Cancer CenterNational Cancer Institute1992–1995
  • Cancer CenterNational Cancer Institute1994
  • Interleukin-1 &Regulation Of HematopoiesisNational Cancer Institute1992–1993
  • Mononuclear Phagocytes, HIV, And HematopoiesisNational Institute Of Diabetes And Digestive And Kidney Diseases1989–1993
  • Monokines In HematopoiesisNational Cancer Institute1987–1991
  • Monokines Which Regulate The Production Of CSANational Cancer Institute1985–1986